Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
James Leech
Advertisement
Articles by James Leech
Advertisement
Latest Updated Articles
Cross-Border Funding in the Life SciencesPublished: August 21st 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
5